Testing effectiveness (Phase 2)Ended earlyNCT00126659
What this trial is testing
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer
Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10